MedEdTalks - Gastroenterology

Share on

MedEdTalks Gastroenterology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on gastroenterology topics, such as ulcerative colitis (UC) and Crohn’s disease and includes interviews with Dr. Peter Higgins…

Vindico Medical Education

May 19, 2023 LATEST EPISODE
monthly NEW EPISODES
16m AVG DURATION
18 EPISODES

Search for episodes from MedEdTalks - Gastroenterology with a specific topic:

Latest episodes from MedEdTalks - Gastroenterology

Diet and Targeted Therapy With Drs. Dellon and Hirano

Play Episode Listen Later May 19, 2023 30:25

In this podcast, expert clinicians will discuss diet considerations and targeted therapy for treatment of EoE.

diet targeted therapy eoe

Steroids and PPIs in the Treatment of EoE With Drs. Dellon and Beveridge

Play Episode Listen Later May 19, 2023 22:48

In this podcast, expert clinicians will discuss the role of steroids and PPIs for treatment of EoE.

treatments steroids beveridge ppis eoe

Differential Diagnosis of EoE With Drs. Dellon and Chehade

Play Episode Listen Later May 19, 2023 26:11

In this podcast, expert clinicians will discuss best practices for the differential diagnosis of EoE.

differential diagnosis eoe

Pearls From the Pros on IBD Management: Anti-Integrin and S1P Receptor Modulation in IBD Practice With Drs. David Rubin and Maria Abreu

Play Episode Listen Later Jan 6, 2022 24:58

In this podcast, expert clinicians discuss the latest updates on anti-integrin therapy and S1P receptor modulators in IBD management.

practice management pros pearls abreu cme medical education ibd gastroenterology receptor modulation david rubin integrin s1p

Pearls From the Pros on IBD Management: JAK Inhibition in IBD Practice With Drs. David Rubin and Millie Long

Play Episode Listen Later Jan 6, 2022 21:07

In this podcast, expert clinicians discuss the latest updates on JAK inhibition in IBD management.

practice management pros jak pearls cme medical education ibd gastroenterology inhibition david rubin

Pearls From the Pros on IBD Management: Anti-IL-12/23 in IBD Practice With Drs. David Rubin and Bruce Sands

Play Episode Listen Later Jan 6, 2022 16:34

In this podcast, expert clinicians discuss the latest updates on anti-IL-12/23 therapy in IBD management.

practice management pros pearls sands cme medical education ibd gastroenterology david rubin

Pearls From the Pros on IBD Management: Anti-TNF Therapy in IBD Practice With Drs. David Rubin and Stephen Hanauer

Play Episode Listen Later Jan 6, 2022 22:22

In this podcast, expert clinicians discuss the latest updates on anti-TNF therapy in IBD management.

practice management therapy pros thursday night football pearls cme medical education ibd gastroenterology david rubin hanauer

Immunogenicity of Current IBD Biologics With Drs. Edward Loftus and Marla Dubinsky

Play Episode Listen Later Aug 18, 2021 13:25

In this podcast, expert clinicians compare the immunogenicity of available biologic therapies and explore options for managing patients who develop anti-drug antibodies.

current cme medical education ibd gastro loftus biologics dubinsky

Extraintestinal Manifestations of IBD With Drs. Edward Loftus and Miguel Regueiro

Play Episode Listen Later Aug 18, 2021 10:36

In this podcast, expert clinicians review the variety of extraintestinal manifestations seen in patients with IBD, discussing strategies for assessment and management.

manifestation cme medical education ibd gastroenterology loftus extraintestinal

Biologics for IBD – Monotherapy Versus Combination Approaches With Drs. Edward Loftus and Marla Dubinsky

Play Episode Listen Later Aug 18, 2021 14:30

In this podcast, experts review appropriate applications of monotherapy and combination therapy and how to position particular therapies based on disease and patient characteristics.

approaches combination cme ibd loftus biologics dubinsky monotherapy

New Insights on Treat to Target in Moderate to Severe IBD With Drs. Edward Loftus and Miguel Regueiro

Play Episode Listen Later Aug 18, 2021 15:19

In this podcast, expert clinicians will discuss the shift from symptom-based management to a treat-to-target paradigm, detailing important treatment aims and reviewing the mechanisms of action of available therapies.

target treat severe moderate cme medical education ibd new insights loftus

Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti

Play Episode Listen Later Mar 16, 2021 16:48

In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-IL-23 and JAK inhibitors, that are in late-stage development for treating moderate to severe CD.

safety cd jak efficacy janus cme inhibitors crohns interleukin kinase william j sandborn

Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn

Play Episode Listen Later Mar 16, 2021 15:37

In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in late-stage development for treating moderate to severe CD.

safety treatments cd sands efficacy cme receptor william j crohn's disease phosphate integrin s1p

Mechanisms of Action of New Classes of Agents for Moderate to Severe Crohn’s Disease with Drs. William J. Sandborn and Bruce E. Sands

Play Episode Listen Later Mar 16, 2021 19:34

In this podcast, expert clinicians will discuss emerging therapies with unique mechanisms of action that can improve the treatment of moderate to severe Crohn’s disease.

action disease treatments cd classes severe crohn sands moderate mechanisms cme crohn's disease william j sandborn

Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 Inhibitors

Play Episode Listen Later Apr 29, 2019 12:25

Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 InhibitorsInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. Peter Higgins and Dr. David Rubin will discuss investigational interleukin-12 and interleukin-23 inhibitors for treating UC. For the transcript of this podcast, click here. To obtain CME credit, click here

united states education medical med talks higgins crohn rubin uc cme gastroenterology ulcerative colitis colitis inhibitors david rubin meded ulcerative peter higgins

Investigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor Modulators

Play Episode Listen Later Apr 29, 2019 9:12

Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. Peter Higgins and Dr. William Sandborn will discuss investigational Janus kinase inhibitors and sphingosine-1-phosphate receptor modulators for treating UC. For the transcript of this podcast, click here. To obtain CME credit, click here

united states education medical disease jak crohn uc janus cme inflammatory ulcerative colitis bowel colitis inhibitors receptor crohns ulcerative peter higgins s1p

Investigational Agents in Ulcerative Colitis: Anti-Integrins

Play Episode Listen Later Apr 25, 2019 9:37

Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. David Rubin and Dr. Peter Higgins will discuss investigational anti-integrin therapies for UC. For the transcript of this podcast, click here To obtain CME credit, click here

united states education medical disease crohn uc cme inflammatory ulcerative colitis bowel colitis crohns david rubin ulcerative peter higgins integrins

Ulcerative Colitis: Targeting Immunological Pathways in Moderate to Severe Disease – Updates From Copenhagen

Play Episode Listen Later Apr 25, 2019 0:48

Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, expert physicians will discuss investigational UC therapies with various mechanisms of action. For the full CME activity, click here

united states education medical disease copenhagen targeting pathways severe crohn uc moderate cme inflammatory gastroenterology ulcerative colitis immunological

Claim MedEdTalks - Gastroenterology

In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

Claim Cancel